Sana Biotechnology (SANA) Common Equity (2020 - 2026)
Sana Biotechnology (SANA) posted Common Equity of $154.57 million for Q2 2026, up 26.1% from $122.56 million a year earlier and up 29.6% from the prior quarter.
Sana Biotechnology (SANA) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Sana Biotechnology's Common Equity came in at $160.88 million, down 35.8% from FY2024.
- Annual Common Equity has declined for four consecutive years.
- In prior years, Sana Biotechnology's Common Equity was $250.5 million in FY2024 (-12.9%), $287.51 million in FY2023 (-42.4%), $499.32 million in FY2022 (-31.5%) and $728.5 million in FY2021.
- Quarterly Common Equity has run from a low of $119.24 million in Q1 2026 to a high of $830.09 million in Q3 2021 over five years.
- On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 28.4%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 26.1%; the weakest was Q2 2025, with a decline of 63.9%.
- According to Business Quant data, Common Equity for the three prior quarters was $119.24 million (Q1 2026), $160.88 million (Q4 2025) and $195.31 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Sana Biotechnology | 876.97 Mn | 876.97 Mn | - | 154.57 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.57 Mn |
| Mar 31, 2026 | 119.24 Mn |
| Dec 31, 2025 | 160.88 Mn |
| Sep 30, 2025 | 195.31 Mn |
| Jun 30, 2025 | 122.56 Mn |
| Mar 31, 2025 | 209.08 Mn |
| Dec 31, 2024 | 250.50 Mn |
| Sep 30, 2024 | 292.48 Mn |
| Jun 30, 2024 | 339.65 Mn |
| Mar 31, 2024 | 375.14 Mn |
| Dec 31, 2023 | 287.51 Mn |
| Sep 30, 2023 | 365.85 Mn |
| Jun 30, 2023 | 355.03 Mn |
| Mar 31, 2023 | 428.26 Mn |
| Dec 31, 2022 | 499.32 Mn |
| Sep 30, 2022 | 566.02 Mn |
| Jun 30, 2022 | 639.51 Mn |
| Mar 31, 2022 | 701.66 Mn |
| Dec 31, 2021 | 728.50 Mn |
| Sep 30, 2021 | 830.09 Mn |
Sana Biotechnology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SANA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SANA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SANA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();